Morphine withdrawal-induced morphological changes in the nucleus accumbens

Saturnino Spiga1, Maria Cristina Puddu, Milena Pisano

  • 1Department of Animal Biology and Ecology, University of Cagliari, Italy.

Insights

Morphine withdrawal significantly reduces dendritic spine density in nucleus accumbens shell neurons, impacting dopamine transmission. This effect, observed during withdrawal but not chronic morphine use, highlights a key change in opioid dependence.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Opioid dependence is associated with altered mesolimbic dopamine transmission.
  • Morphine withdrawal is known to cause hypofunction of mesencephalic dopamine neurons.
  • Medium spiny neurons (MSN) in the nucleus accumbens are key targets of dopamine.

Purpose of the Study:

  • To investigate the morphological changes in nucleus accumbens MSN during morphine withdrawal.
  • To determine if chronic morphine treatment itself, or withdrawal, affects MSN morphology.
  • To differentiate the effects on core and shell regions of the nucleus accumbens.

Main Methods:

  • Chronic morphine administration to rats at escalating doses.
  • Induction of spontaneous and naloxone-precipitated morphine withdrawal.
  • Golgi-Cox staining of MSN followed by confocal laser-scanning microscopy (CLSM) analysis.

Main Results:

  • Morphine withdrawal, both spontaneous and precipitated, significantly reduced spine density in shell MSN.
  • This reduction was selectively localized to second-order dendritic trunks.
  • Chronic morphine treatment alone did not alter MSN perikarya size or spine density.

Conclusions:

  • Morphine withdrawal, not chronic morphine use per se, alters MSN spine density in the nucleus accumbens.
  • The observed reduction in spine density is specific to the shell region of the nucleus accumbens.
  • These morphological changes likely contribute to the hypodopaminergic state characteristic of opioid dependence.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...